How to buy Innospec (IOSP) stock

Innospec Inc is a specialty chemicals business based in the US. Innospec shares (IOSP) are listed on the NASDAQ and all prices are listed in US Dollars. Innospec employs 1,900 staff and has a trailing 12-month revenue of around 0.00.

Innospec stock price (NASDAQ: IOSP)

Use our graph to track the performance of IOSP stocks over time.

Innospec shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$101.11
52-week range	$60.74 - $107.15
50-day moving average	$93.17
200-day moving average	$98.03
Wall St. target price	$114.50
PE ratio	112.7225
Dividend yield	$1.04 (1.19%)
Earnings per share (TTM)	$0.76

Buy Innospec shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Innospec stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Innospec Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Innospec price performance over time

Historical closes compared with the close of $101.11 from 2021-05-28

1 week (2021-07-14)	N/A
1 month (2021-06-25)	7.56%
3 months (2021-04-21)	N/A
6 months (2021-01-21)	N/A

1 year (2020-07-21)	N/A
2 years (2019-07-21)	N/A
3 years (2018-07-21)	N/A
5 years (2016-07-21)	N/A

Is Innospec under- or over-valued?

Valuing Innospec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Innospec's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Innospec's P/E ratio

Innospec's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 113x. In other words, Innospec shares trade at around 113x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Innospec's EBITDA

Innospec's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $111 million.

The EBITDA is a measure of a Innospec's overall financial performance and is widely used to measure a its profitability.

Innospec financials

Revenue TTM	$1.2 billion
Operating margin TTM	5.78%
Gross profit TTM	$342.7 million
Return on assets TTM	2.91%
Return on equity TTM	2%
Profit margin	1.64%
Book value	$38.96
Market capitalisation	$2.1 billion

TTM: trailing 12 months

Shorting Innospec shares

There are currently 204,300 Innospec shares held short by investors – that's known as Innospec's "short interest". This figure is 33.2% down from 305,787 last month.

There are a few different ways that this level of interest in shorting Innospec shares can be evaluated.

Innospec's "short interest ratio" (SIR)

Innospec's "short interest ratio" (SIR) is the quantity of Innospec shares currently shorted divided by the average quantity of Innospec shares traded daily (recently around 116079.54545455). Innospec's SIR currently stands at 1.76. In other words for every 100,000 Innospec shares traded daily on the market, roughly 1760 shares are currently held short.

However Innospec's short interest can also be evaluated against the total number of Innospec shares, or, against the total number of tradable Innospec shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Innospec's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Innospec shares in existence, roughly 10 shares are currently held short) or 0.0084% of the tradable shares (for every 100,000 tradable Innospec shares, roughly 8 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Innospec.

Find out more about how you can short Innospec stock.

Innospec share dividends

Dividend payout ratio: 38.11% of net profits

Recently Innospec has paid out, on average, around 38.11% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.31% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Innospec shareholders could enjoy a 1.31% return on their shares, in the form of dividend payments. In Innospec's case, that would currently equate to about $1.04 per share.

While Innospec's payout ratio might seem fairly standard, it's worth remembering that Innospec may be investing much of the rest of its net profits in future growth.

Innospec's most recent dividend payout was on 25 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 May 2021 (the "ex-dividend date").

Have Innospec's shares ever split?

Innospec's shares were split on a 2:1 basis on 22 July 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Innospec shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Innospec shares which in turn could have impacted Innospec's share price.

Innospec share price volatility

Over the last 12 months, Innospec's shares have ranged in value from as little as $60.7368 up to $107.145. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Innospec's is 1.3079. This would suggest that Innospec's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Innospec overview

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. It operates through Fuel Specialties, Performance Chemicals, and Oilfield Services segments. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and maintain asset integrity.

Frequently asked questions

What percentage of Innospec is owned by insiders or institutions?
Currently 1.195% of Innospec shares are held by insiders and 97.401% by institutions. How many people work for Innospec?
Latest data suggests 1,900 work at Innospec. When does the fiscal year end for Innospec?
Innospec's fiscal year ends in December. Where is Innospec based?
Innospec's address is: 8310 South Valley Highway, Englewood, CO, United States, 80112 What is Innospec's ISIN number?
Innospec's international securities identification number is: US45768S1050 What is Innospec's CUSIP number?
Innospec's Committee on Uniform Securities Identification Procedures number is: 45768S105